New Stock News | Ginoja submitted to the Hong Kong Stock Exchange

According to the Wise Finance APP, it was revealed by the Hong Kong Stock Exchange on December 21 that Jiyinjia Technology (Shaoxing) Co., Ltd. (referred to as Jiyinjia) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with China International Capital Corporation and Minsheng Capital as its joint sponsors. The prospectus shows that Jiyinjia is a leading precision medical company in China, deeply embedding AI capabilities into various core links of the biomarker value chain. Based on its independently developed multi-omics platform, combined with basic large models and intelligent AI, the company has built a full-chain ability from the discovery, verification, product development of multi-omics biomarkers and targets to commercialization. Therefore, the company provides three major solutions to hospitals, pharmaceutical and biotechnology companies, medical research institutions, etc.: precision diagnosis, empowering drug development, and clinical research and transformation.